Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. V. Leonenkov
Efficacy and Safety of Lenvatinib in Combination With Everolimus in Metastatic Renal Cell Carcinoma Resistant to Antiangiogenic Targeted Therapy: Russian Multicenter Observational Study ROSLERCM
Onkourologiya
Oncology
Radiology
Urology
Nuclear Medicine
Nephrology
Imaging
Surgery
Related publications
Pcn92 - The Evaluation of the Economic Efficiency of Lenvatinib in Combination With Everolimus in Russian Patients With Disseminated Renal Cell Carcinoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Pilot Study of Antiangiogenic Therapy With Bevacizumab and Thalidomide in Patients With Metastatic Renal Cell Carcinoma
Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer Research
Allergy
Immunology
Pharmacology
Efficacy of Targeted Therapy for Metastatic Renal Cell Carcinoma in the Elderly Patient Population
Clinical Genitourinary Cancer
Oncology
Urology
Metastatic Renal Cell Carcinoma: Radiologic Findings and Assessment of Response to Targeted Antiangiogenic Therapy by Using Multidetector CT
Radiographics
Medicine
Nuclear Medicine
Radiology
Imaging
Safety and Efficacy of Combination Therapy With Apatinib and Doxorubicin in Metastatic Soft Tissue Sarcomas: An Observational Study From Multiple Institutions
Cancer Management and Research
Oncology
Molecular Subtyping of Metastatic Renal Cell Carcinoma: Implications for Targeted Therapy
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
A Phase I/Ii Trial of BNC105P With Everolimus in Metastatic Renal Cell Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
Metastatic Renal Cell Carcinoma With Level IV Thrombus: Contemporary Management With Complete Response to Neoadjuvant Targeted Therapy
Case Reports in Urology
Molecular Markers Associated With the Response to Therapy With Everolimus in Patients With Renal Cell Carcinoma
Siberian Journal of Oncology
Cancer Research
Oncology
